Acute Treatment of Migraine

被引：18
作者：
Tepper, Stewart J. [1 ,2 ,3 ]
机构：
[1] Geisel Sch Med Dartmouth, Hanover, NH USA
[2] Dartmouth Headache Ctr, Lebanon, NH USA
[3] Dartmouth Hitchcock Med Ctr, Neurol Dept, 1 Med Ctr Dr, Lebanon, NH 03748 USA
来源：
NEUROLOGIC CLINICS | 2019年 / 37卷 / 04期
关键词：
Acute migraine treatment; Migraine; Triptans; Ergots; Gepants; Ditans; NSAIDs; Neuroleptics; ACUTE TREATMENT OPTIMIZATION; DOUBLE-BLIND; PARALLEL-GROUP; EPISODIC MIGRAINE; CARE STRATEGIES; OPIOID USE; HEADACHE; PLACEBO; EFFICACY; STIMULATION;
D O I：
10.1016/j.ncl.2019.07.006
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
All patients with migraine merit acute treatment, which should optimally achieve a sustained pain-free response. Maximum acute treatment is associated with reduced risk of transformation of episodic to chronic migraine. The American Headache Society published the most recent complete evidence assessment of acute migraine treatments in 2015. Noninvasive neuromodulation represents a new, Food and Drug Administration-approved nonsignificant risk alternative for acute migraine therapy. The future of acute migraine treatment includes new devices and formulations of existing medications, new classes of acute medications, and new noninvasive nonsignificant risk neuromodulation devices, with many anticipated in the next few years.
引用
收藏
页码：727 / +
页数：17
相关论文
共 45 条
[1]   Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program [J].
Bhola, Ria ;
Kinsella, Evelyn ;
Giffin, Nicola ;
Lipscombe, Sue ;
Ahmed, Fayyaz ;
Weatherall, Mark ;
Goadsby, Peter J. .
JOURNAL OF HEADACHE AND PAIN, 2015, 16
[2]   Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study [J].
Bigal, Marcelo E. ;
Serrano, Daniel ;
Buse, Dawn ;
Scher, Ann ;
Stewart, Walter F. ;
Lipton, Richard B. .
HEADACHE, 2008, 48 (08) :1157-1168
[3]   Ergotamine and dihydroergotamine: A review [J].
Marcelo E. Bigal ;
Stewart J. Tepper .
Current Pain and Headache Reports, 2003, 7 (1) :55-62
[4]   Sumatriptan-naproxen for acute treatment of migraine - A randomized trial [J].
Brandes, Jan Lewis ;
Kudrow, David ;
Stark, Stuart R. ;
O'Carroll, C. Phillip ;
Adelman, James U. ;
O'Donnell, Francis J. ;
Alexander, W. James ;
Spruill, Susan E. ;
Barrett, Pamela S. ;
Lener, Shelly E. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13) :1443-1454
[5]   Opioid Use and Dependence Among Persons With Migraine: Results of the AMPP Study [J].
Buse, Dawn C. ;
Pearlman, Starr H. ;
Reed, Michael L. ;
Serrano, Daniel ;
Ng-Mak, Daisy S. ;
Lipton, Richard B. .
HEADACHE, 2012, 52 (01) :18-36
[6]  
Chou DE, 2017, CEPHALALGIA, V37, P323
[7]   DICLOFENAC-K (50 AND 100 MG) AND PLACEBO IN THE ACUTE TREATMENT OF MIGRAINE [J].
DAHLOF, C ;
BJORKMAN, R .
CEPHALALGIA, 1993, 13 (02) :117-123
[8]   Efficacy and tolerability of diclofenac potassium sachets in migraine:: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo [J].
Diener, HC ;
Montagna, P ;
Gács, G ;
Lyczak, P ;
Schumann, G ;
Zöller, B ;
Mulder, LJMM ;
Siegel, J ;
Edson, K .
CEPHALALGIA, 2006, 26 (05) :537-547
[9]   Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire [J].
Dowson, AJ ;
Tepper, SJ ;
Baos, V ;
Baudet, F ;
D'Amico, D ;
Kilminster, S .
CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (07) :1125-1135
[10]   Migraine chronobiology [J].
Fox, AW ;
Davis, RL .
HEADACHE, 1998, 38 (06) :436-441
12345